Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$45.1M |
| 2 |
Cisco
CSCO
|
+$38.8M |
| 3 |
Oracle
ORCL
|
+$37M |
| 4 |
DuPont de Nemours
DD
|
+$36.5M |
| 5 |
Eli Lilly
LLY
|
+$30.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$61.2M |
| 2 |
Wells Fargo
WFC
|
+$52.2M |
| 3 |
Amazon
AMZN
|
+$49.5M |
| 4 |
Chemours
CC
|
+$49.3M |
| 5 |
Pfizer
PFE
|
+$44.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.09% |
| 2 | Industrials | 17.32% |
| 3 | Healthcare | 15.49% |
| 4 | Consumer Discretionary | 13.3% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
General Dynamics
GD
$104B
| $21.3M | 0.34% |
117,372
-226,608
| -66% | -$39M |
|
|
TWTR
77
DELISTED
Twitter, Inc.
TWTR
| $21M | 0.34% |
602,402
+590,778
| +5,082% | +$21.7M |
|
78
Berkshire Hathaway Class B
BRK.B
$1.06T
| $20.8M | 0.33% |
97,666
-58,479
| -37% | -$12.1M |
|
79
Amgen
AMGN
$238B
| $20.5M | 0.33% |
111,505
-91,812
| -45% | -$16.4M |
|
80
FedEx
FDX
$76.9B
| $20.4M | 0.33% |
124,164
+117,919
| +1,888% | +$20.6M |
|
81
Best Buy
BBY
$18.1B
| $20M | 0.32% |
286,217
+170,071
| +146% | +$11.9M |
|
82
International Paper
IP
$22B
| $19.9M | 0.32% |
484,103
+130,395
| +37% | +$5.52M |
|
83
TE Connectivity
TEL
$58.9B
| $19.9M | 0.32% |
207,270
-150,579
| -42% | -$13.6M |
|
84
NetApp
NTAP
$37.7B
| $19.6M | 0.31% |
317,469
+10,384
| +3% | +$701K |
|
85
Devon Energy
DVN
$54B
| $19.5M | 0.31% |
683,393
+256,074
| +60% | +$7.61M |
|
86
McKesson
MCK
$100B
| $19.5M | 0.31% |
144,744
+127,340
| +732% | +$15.9M |
|
87
Gilead Sciences
GILD
$181B
| $19.2M | 0.31% |
284,192
+44,776
| +19% | +$2.95M |
|
88
Humana
HUM
$45.5B
| $18.9M | 0.3% |
71,419
+58,787
| +465% | +$14.9M |
|
89
American Express
AXP
$227B
| $18.9M | 0.3% |
152,879
+119,813
| +362% | +$14.1M |
|
90
Henry Schein
HSIC
$9.86B
| $18.8M | 0.3% |
268,799
+97,837
| +57% | +$6.47M |
|
91
Ross Stores
ROST
$76.7B
| $18.7M | 0.3% |
188,989
+134,208
| +245% | +$13.1M |
|
92
Colgate-Palmolive
CL
$72.6B
| $18.6M | 0.3% |
259,927
+17,503
| +7% | +$1.24M |
|
93
AutoZone
AZO
$48.3B
| $18.5M | 0.3% |
16,830
-13,357
| -44% | -$14.1M |
|
|
GRMN
94
Garmin
GRMN
$56.9B
| $18.3M | 0.29% |
229,876
-131,927
| -36% | -$10.8M |
|
95
Blackrock
BLK
$179B
| $18.2M | 0.29% |
38,880
-10,957
| -22% | -$4.96M |
|
96
Trane Technologies
TT
$99.8B
| $18M | 0.29% |
142,371
-117,307
| -45% | -$14M |
|
97
Corpay
CPAY
$27.4B
| $18M | 0.29% |
+64,213
| New | +$16.8M |
|
98
Omnicom Group
OMC
$24B
| $17.9M | 0.29% |
218,977
-3,755
| -2% | -$296K |
|
|
99
Pfizer
PFE
$160B
| $17.8M | 0.28% |
434,019
-1,122,287
| -72% | -$44.6M |
|
100
Mondelez International
MDLZ
$82.3B
| $17.6M | 0.28% |
326,770
+149,179
| +84% | +$7.75M |
|
Similar funds
Joel Greenblatt's Q2 2019 Portfolio in Review
As of Q2 2019, Joel Greenblatt held 1,366 positions worth $6.27B, down 8.2% from $6.83B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Joel Greenblatt withdrew a net $642M in Q2 2019, closing 251 positions and reducing 489 holdings. Its most notable exit was Chemours, an estimated $49.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Joel Greenblatt opened a new position in Intuit worth $46.3M.
- Joel Greenblatt's largest Q2 2019 buy was Intuit: 177,339 shares worth $46.3M.
- Joel Greenblatt added most to Cisco in Q2 2019, an estimated $38.8M increase.
- Joel Greenblatt's biggest Q2 2019 reduction was PayPal, cutting an estimated $61.2M.
- Joel Greenblatt fully exited Chemours in Q2 2019, selling an estimated $49.3M.
- Joel Greenblatt's ten largest holdings make up 10% of its $6.27B portfolio in Q2 2019.
- Joel Greenblatt opened 206 new positions and closed 251 in Q2 2019.
- Joel Greenblatt's portfolio value fell 8.2% quarter-over-quarter to $6.27B.
Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.